Physician profile
Wanda A Brady
NPI 1033186010
$955.28
in general payments reported to CMS, 2019-2025
10 companies · $45.30 in 2025
The $45.30 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.89 · 2021: $178 · 2022: $267 · 2023: $368 · 2024: $64.09 · 2025: $45.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.65 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $282.71 | 2021-2022 | |
| Abbvie INC. | $252.19 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $132.09 | 2020-2025 | Slynd, Nuvessa |
| Astellas Pharma US INC | $131.87 | 2023 | Veozah |
| Therapeuticsmd, INC. | $37.51 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.98 | 2023 | |
| Mayne Pharma Commercial LLC | $25.54 | 2025 | |
| Exact Sciences Corporation | $22.62 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $22.16 | 2023 | Myfembree |
| Coopersurgical, INC. | $20.61 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.